INS and endometrial cancer: hsa_circRNA_402632 has the potential to enrich the insulin resistance pathway and hsa_circRNA_405481 affects the endometrial cancer signaling pathway, Fc epsilon RI signaling pathway, and TGF-beta signaling pathway, both of which may be related to inflammatory response.